HLA-B81
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
| major histocompatibility complex (human), class I, B81
| ||
| Alleles | B*8101 | |
| Structure (See HLA-B) | ||
| Symbol(s) | HLA-B | |
| EBI-HLA | B*8101 | |
| Locus | chr.6 6p21.31 | |
HLA-B81 (B81) is an HLA-B serotype. The serotype identifies the HLA-B*8101 and B*8102 (very rare) gene products.[1] B81 is more common in Subsaharan Africa. While there is a B81 serotype, serotyping of B81 is poor when simultaneously tested with anti-B7 or B48 antibodies.[2] (For terminology help see: HLA-serotype tutorial)
Serotype
| B*81 | B81 | B7 | Sample |
| allele | % | % | size (N) |
| 8101 | 8 | 76 | 657 |
The serotype recognition of B*8101 is poor and is best identified by genetic techniques such as SSP-PCR and gene sequencing.
Allele frequencies
| freq | ||
| ref. | Population | (%) |
| [4] | Luo (Kenya) | 6.2 |
| [4] | Yaounde (Cameroon) | 4.4 |
| [4] | Shona (Harare, Zimbabwe) | 4.0 |
| [4] | Nandi (Kenya) | 4.0 |
| [4] | Tswana (South Africa) | 3.7 |
| [4] | Natal Zulu (South African) | 3.5 |
| [4] | Baloch (Iran) | 3.5 |
| [4] | Kenya | 2.8 |
| [4] | Pazeh (Taiwan) | 2.7 |
| [4] | Lusaka (Zambia) | 2.3 |
| [4] | Bakola Pygmy (Cameroon) | 2.0 |
| [4] | Beti (Cameroon) | 1.7 |
| [4] | Oman | 1.3 |
| [4] | Bamileke (Cameroon) | 1.3 |
| [4] | United Arab Emerates | 1.1 |
| [4] | Southern Portugal | 1.0 |
| [4] | Kampala (Uganda) | 0.9 |
| [4] | Sudanese | 0.5 |
| [4] | Delhi (India) | 0.5 |
| [4] | Brazil Parana Mulatto | 0.5 |
| [4] | Romanian | 0.3 |
| [4] | Chinese (Hong Kong, China) | 0.2 |
| [4] | Shijiazhuang Tianjian (Beijing, China) | 0.2 |
| [4] | South Korea | 0.1 |
HLA-B81 corresponds to a single allele B*8101. There are no characterized haplotypes of this allele that span multiple regions, though rare haplotypes certainly exist. The frequency in Kenya, Zimbabwe and Cameroon suggest that B81 probably expanded from core groups of Africans in Tanzania, Zambia or the Congo but with a limited spread do to its initial low frequency.
References
- ↑ Marsh SG, Albert ED, Bodmer WF, et al (2005). "Nomenclature for factors of the HLA system, 2004". Tissue Antigens 65 (4): 301–69. doi:10.1111/j.1399-0039.2005.00379.x. PMID 15787720.
- ↑ Ellexson ME, Zhang G, Stewart D, et al (1995). "Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens". Hum. Immunol. 44 (2): 103–10. PMID 8847228.
- ↑ derived from IMGT/HLA
- ↑ 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18 4.19 4.20 4.21 4.22 4.23 Middleton D, Menchaca L, Rood H, Komerofsky R (2003). "New allele frequency database: http://www.allelefrequencies.net". Tissue Antigens 61 (5): 403-7. PMID 12753660.
HLA-B Serotypes and allele groups |
|---|
| HLA-B - B5 (B51 - B52) - B7 - B8 - B12 (B44 - B45) - B13 - B14]] (B64 - B65) - B15 (B62 - B63 - B70 - B71- B75 - B76 - B77) - B16 (B38 - B39) - B17 (B57 - B58) - B18 - B21 (B49 - B50) - B22 (B54 - B55 - B56) - B27 - B35 - B37 - B40 (B60 - B61) - B41 - B42 - B46 - B47 - B48 - B53 - B59 - B67 - B73 - B78 - B81 - B*82 - B*83 |
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
